[Guidelines for the diagnosis and treatment of obstructive sleep apnea in adults (2025)] - PubMed
a day ago
- #clinical guidelines
- #sleep apnea
- #respiratory health
- Guidelines for the diagnosis and treatment of obstructive sleep apnea (OSA) in adults (2025) have been updated to reflect current evidence.
- OSA is a prevalent sleep-related breathing disorder with significant healthcare burdens.
- The 2011 guideline was based on expert consensus, but the 2025 version is evidence-based.
- The guidelines aim to standardize screening, diagnosis, treatment, and long-term management of OSA.
- 18 key clinical questions are addressed with detailed recommendations.
- Screening is recommended for high-risk populations, not the general population.
- High-risk populations include those with typical symptoms, physical signs, comorbidities, or family history of OSA.
- The STOP-Bang questionnaire is recommended for OSA screening.
- Polysomnography (PSG) is the gold standard for diagnosing OSA.
- Home sleep apnea testing (HSAT) is recommended for moderate-to-severe uncomplicated OSA.
- OSA severity is classified based on the apnea-hypopnea index (AHI).
- Comprehensive management of OSA should be multidisciplinary and individualized.
- Positive airway pressure (PAP) therapy is first-line treatment for moderate-to-severe OSA.
- Oral appliance therapy is recommended for primary snoring and mild-to-moderate OSA.
- Upper airway surgery may be considered for patients intolerant to PAP therapy.
- Pharmacological therapy is not recommended as routine treatment but may be adjunctive for specific cases.
- Long-term follow-up should assess symptoms, treatment adherence, and quality of life.
- Telemedicine is valuable for remote diagnosis, treatment, and follow-up of OSA.